1 month TD Cowen Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $371.00MarketBeat
TD Cowen upped their price objective on shares of Alnylam Pharmaceuticals from $282.00 to $371.00 and gave the company a “buy” rating in a research note on Monday.
Nasdaq 100 · Pharmaceuticals · Science
X